Clinical Connection

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia

Sponsor: Avanir Pharmaceuticals

Question 1 of 6

Is the potential participant 18 to 60 years of age?